CN108606327A - It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect - Google Patents
It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect Download PDFInfo
- Publication number
- CN108606327A CN108606327A CN201810439855.2A CN201810439855A CN108606327A CN 108606327 A CN108606327 A CN 108606327A CN 201810439855 A CN201810439855 A CN 201810439855A CN 108606327 A CN108606327 A CN 108606327A
- Authority
- CN
- China
- Prior art keywords
- parts
- alimentation composition
- muscle
- vitamin
- increasing function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 230000000694 effects Effects 0.000 title abstract description 25
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 22
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 21
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 20
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 claims abstract description 18
- 229940108924 conjugated linoleic acid Drugs 0.000 claims abstract description 18
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 18
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 18
- 102000008186 Collagen Human genes 0.000 claims abstract description 16
- 108010035532 Collagen Proteins 0.000 claims abstract description 16
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 16
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 16
- 229920001436 collagen Polymers 0.000 claims abstract description 16
- 239000005862 Whey Substances 0.000 claims abstract description 15
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 12
- 239000011707 mineral Substances 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims abstract description 11
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 11
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 11
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 11
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 11
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000012680 lutein Nutrition 0.000 claims abstract description 10
- 229960005375 lutein Drugs 0.000 claims abstract description 10
- 239000001656 lutein Substances 0.000 claims abstract description 10
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 10
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 10
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 10
- 229940046009 vitamin E Drugs 0.000 claims abstract description 10
- 239000011709 vitamin E Substances 0.000 claims abstract description 10
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 10
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960002061 ergocalciferol Drugs 0.000 claims abstract description 9
- 235000001892 vitamin D2 Nutrition 0.000 claims abstract description 9
- 239000011653 vitamin D2 Substances 0.000 claims abstract description 9
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- NXMUXTAGFPJGTQ-UHFFFAOYSA-N decanoic acid;octanoic acid Chemical compound CCCCCCCC(O)=O.CCCCCCCCCC(O)=O NXMUXTAGFPJGTQ-UHFFFAOYSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 150000005691 triesters Chemical class 0.000 claims description 5
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 claims description 3
- 235000013402 health food Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229920001542 oligosaccharide Polymers 0.000 claims description 3
- 150000002482 oligosaccharides Chemical class 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 abstract description 20
- 238000000354 decomposition reaction Methods 0.000 abstract description 4
- 230000002776 aggregation Effects 0.000 abstract description 3
- 238000004220 aggregation Methods 0.000 abstract description 3
- 235000019197 fats Nutrition 0.000 abstract description 3
- 102000008934 Muscle Proteins Human genes 0.000 abstract description 2
- 108010074084 Muscle Proteins Proteins 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 10
- 235000010755 mineral Nutrition 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 8
- 102000004407 Lactalbumin Human genes 0.000 description 7
- 108090000942 Lactalbumin Proteins 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- -1 carrotene Proteins 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZBCATMYQYDCTIZ-UHFFFAOYSA-N 4-methylcatechol Chemical compound CC1=CC=C(O)C(O)=C1 ZBCATMYQYDCTIZ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102100032241 Lactotransferrin Human genes 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical group CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000001076 sarcopenia Diseases 0.000 description 1
- 210000001908 sarcoplasmic reticulum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 102000009310 vitamin D receptors Human genes 0.000 description 1
- 108050000156 vitamin D receptors Proteins 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a kind of alimentation composition and preparation method thereof for having and increasing flesh effect, raw material includes 120 140 parts of PURE WHEY, 1 1.5 parts of conjugated linoleic acid, 12 parts of medium chain triglyceride, 34 parts of collagen peptide, 0.1 0.3 parts of vitamin C, 0.1 0.3 parts of calciferol, 0.1 0.3 parts of vitamin E, newborn 5 15 parts of mineral salt, 38 parts of lutein, 38 parts of zeaxanthin;The alimentation composition can improve the tolerance of muscle, reduce the aggregation of fat, inhibit the decomposition of albumen, reduce the loss of muscle protein, promote the reparation of body, improve locomitivity.
Description
Technical field
The invention belongs to healthy food fields, and in particular to a kind of to have the alimentation composition for increasing flesh effect and its preparation side
Method.
Background technology
In recent years, body building is socially fashionable, during the motion, can consume a large amount of energy, lasting movement
Amount can cause protein catabolism to be reinforced, and cause muscle strength to increase, muscle strength increase easily leads to pulled muscle.To movement
Personage supplements enough nutrient proteins, can effectively reduce the decomposition of muscle protein, restores muscle vitality, increases the conjunction of protein
At, reduce fat aggregation, improve tolerance, increase muscular energy.More and more bodybuilders, which start to take, increases flesh class
Nutriment, this kind of nutriment is again with the most commonly used of " albumen powder ".Protein is the foundation stone that muscle is constituted and muscle life
Long basis cannot lack protein if it is desired to increasing muscle.
As prior art CN201711383585X discloses a kind of PURE WHEY with increasing flesh effect, including sea cucumber
Oligopeptide, whey protein concentrate, sepg whey albumen, UF membrane casein, medium chain triglyceride, pass through the supplement of albumen, energy
Enough rapid, lasting supplement energy, quickly increase flesh.
Prior art CN2012104239794 discloses a kind of composite protein powder of anti-sarcopenia decaying, including
Lactalbumin, collagen peptide, amino acid, vitamin, carrotene, MCT, creatine, lecithin, and with albumen be it is main
Raw material has effects that the component for centainly increasing flesh is used cooperatively with other.
Lactalbumin is worth with good sport nutrition, and containing abundant branched-chain amino acid, and branched-chain amino acid has
Muscle breakdown is prevented, it is mostly using lactalbumin as major ingredient to promote the effect of muscle synthesis, nutrient powder, other nutritional ingredients of compatibility are real
Now increase the purpose of flesh.
Prior art research, a certain amount of lactalbumin can stimulate bone to generate maximum albumen synthesis, and
It is not that lactalbumin intake is The more the better, albumen intake stimulation increases flesh effect, and there are the upper limits, may be logical with albumen anabolism
The expression quantity of certain albumen or activity reach capacity to the reaction of amino acid stimulation related on the road, it is also possible to high concentration whey egg
Caused by white active cell catabolism, therefore when research increases the albumen powder of flesh effect, need how research further enhances
Albumen stimulation increases the upper limit problem of flesh.
Invention content
The invention reside in provide a kind of alimentation composition and preparation method thereof for having and increasing flesh effect, one side Abundant protein powder
Nutritional ingredient can further improve and increase flesh effect, reach rapid, lasting supplement by the collaboration compatibility of various ingredients
On the other hand the purpose of ability improves the tolerance of muscle, reduce the aggregation of fat, inhibits the decomposition of albumen, reduces muscle egg
White loss promotes the reparation of body, improves locomitivity.
Technical solution of the present invention is as follows.
At least two compositions in conjugated linoleic acid, medium chain triglyceride and PURE WHEY have in manufacture to be increased
Flesh acts on the purposes in alimentation composition, and the alimentation composition can be functional food, health food, drug.
For medium chain triglyceride, has many research addition medium chain triglycerides at present and increase flesh effect, middle chain to improve
Triglycerides has the characteristics that high energy, digestible, while providing energy, reduces the decomposition of protein.
For conjugated linoleic acid, it is the naturally occurring free fatty containing conjugated double bond with 18 carbon, there is reality
The life span of mouse under anoxic conditions can be significantly improved by testing research conjugated linoleic acid.Conjugated linoleic acid can promote cardiac muscle and
The expression of Skeletal Muscle Lactoferrin increases myoglobin content, can reduce fat content, increases protein content.
More crucially, conjugated linoleic acid can increase the content of musculature while reducing body fat tissue,
Has the function of repartitioning function.
On the basis of what the present invention studied focuses on using lactalbumin as primary raw material, selection of how arranging in pairs or groups can obtain
Increase the better alimentation composition of flesh effect.The study found that after adding medium chain triglyceride and conjugated linoleic acid, with lactalbumin
In the case of powder and other relevant material combinations, there is apparent increasing flesh effect.
Further, the composition forms are tablet, capsule, electuary, granule, one kind in pill or more
Kind, can be health food, functional food or drug.
Further, the composition includes 100-150 parts of PURE WHEY, 1-2 parts of conjugated linoleic acid, medium chain triglyceride three
1-4 parts of ester.
Further, the composition further includes 3-5 parts of collagen peptide, 0.1-0.5 parts of vitamin C, calciferol
0.1-0.5 parts, 0.1-0.5 parts of vitamin E, newborn 5-20 parts of mineral salt, 3-10 parts of lutein, 3-10 parts of zeaxanthin.
The shortage and skeletal muscle fibre of vitamin D, especially II type muscle fibre have direct relationship, vitamin D that can lead to
It crosses and is combined with the vitamin D receptor of Skeletal Muscle Cell surface specific, so that the expression of mRNA is increased, promote the synthesis of muscle fibre,
On the other hand, vitamin D can be such that sarcoplasmic reticulum storage calcium increases, and promote contraction of muscle function.Vitamin C fights the work of muscle decaying
Related for its antioxidation, ascorbic shortage can influence physical performance from many aspects, including nonspecific
Fatigue symptom, myasthenia etc..
For with increase flesh effect " nutrient powder ", it is desirable to realization while increasing flesh, disclosure satisfy that nutrition
It is comprehensive, and absorption of the body to nutritional ingredient can be promoted.For example mineral salts appropriate are supplemented, and immune, metabolism is related
Nutritional ingredient etc., to meet the needs of body.
Therefore, on the basis of existing research, research adds newborn mineral salt, lutein and zeaxanthin further to improve
The increasing flesh effect of the alimentation composition.
Further, the composition component is 120-140 parts of PURE WHEY, 1-1.5 parts of conjugated linoleic acid, middle chain
1-2 parts of triglycerides, 3-4 parts of collagen peptide, 0.1-0.3 parts of vitamin C, 0.1-0.3 parts of calciferol, vitamin E
0.1-0.3 parts, newborn 5-15 parts of mineral salt, 3-8 parts of lutein, 3-8 parts of zeaxanthin.
Further, collagen peptide is deep-sea fish collagen peptide, bone collagen peptide, and the two proportioning is 3-5:1-2;
Medium chain triglyceride is Glycerin, mixed triester with caprylic acid capric acid.
Further, the composition further comprises conventional auxiliary material, including starch, magnesium stearate, cellulose, titanium dioxide
It is one or more in silicon, talcum powder, maltodextrin, oligosaccharide.
The invention further relates to a kind of preparation methods of the alimentation composition with muscle-increasing function, including:
Accurately weigh each raw material component;
It pelletizes after above-mentioned raw materials are sufficiently mixed.
Further, each raw material is dry powder doses;Further pass through UHT sterilization treatments after granulation.
Further, above method raw material further includes 1-5 parts of maltodextrin, 1-5 parts of oligosaccharide.
The beneficial effects of the invention are as follows can quickly regain one's strength, and improve the tolerance of human body.It is sub- by adding conjugation
The compatibility effect of oleic acid and medium chain triglyceride can further promote the absorption of albumen, reduce the loss of albumen, mitigate tired
Labor sense improves endurance, and improves the bottleneck for increasing flesh to a certain extent.Compared with general proteins powder, human body can obviously improve
Body fat ratio and muscle weight are suitable for increasing flesh crowd or muscle decaying crowd use.
Embodiment 1
With the alimentation composition for increasing flesh effect, 120 parts of PURE WHEY, 1 part of conjugated linoleic acid, 1 part of Glycerin, mixed triester with caprylic acid capric acid, glue
3 parts of former protein peptides, 0.15 part of vitamin C, 0.1 part of calciferol, 0.15 part of vitamin E, newborn 5 parts of mineral salt, lutein 3
Part, 3 parts of zeaxanthin.
Embodiment 2
140 parts of PURE WHEY, 1.5 parts of conjugated linoleic acid, 2 parts of Glycerin, mixed triester with caprylic acid capric acid, 4 parts of collagen peptide, vitamin C 0.2
Part, 0.2 part of calciferol, 0.2 part of vitamin E, newborn 10 parts of mineral salt, 4 parts of lutein, 4 parts of zeaxanthin.
Comparative example 1
With the alimentation composition for increasing flesh effect, 120 parts of PURE WHEY, 3 parts of collagen peptide, 0.15 part of vitamin C, dimension
Raw 0.1 part of element D2,0.15 part of vitamin E, newborn 5 parts of mineral salt, 3 parts of lutein, 3 parts of zeaxanthin.
Comparative example 2
With increase flesh effect alimentation composition, 120 parts of PURE WHEY, 0.1 part of conjugated linoleic acid, 1 part of Glycerin, mixed triester with caprylic acid capric acid,
80 parts of collagen peptide, 0.15 part of vitamin C, 0.1 part of calciferol, 0.15 part of vitamin E, newborn 5 parts of mineral salt, leaf are yellow
Plain 3 parts, 3 parts of zeaxanthin.
Comparative example 3
140 parts of PURE WHEY, 4 parts of collagen peptide, 0.2 part of vitamin C, 0.2 part of calciferol, 0.2 part of vitamin E,
10 parts of newborn mineral salt.
Increase flesh effect assessment
Selected from the volunteer with increasing flesh wish for coming from fitness center, 7 groups are arranged altogether, every group of 9 people, are adult male,
Age, height, weight no significant difference, physical condition are good.Body fat is measured using DX200 super strong type body composition measurement instrument
Index and muscle weight measure muscle strength using the sleeping drawing that pushes away and crouch of barbell.
Experimental group and control group arrange increasing flesh training time, mode identical daily, no longer arrange other training, test component
The composition described in embodiment 1, embodiment 2 and comparative example 1-3 An Pai not be taken, normal control group is set as taking the breast of equivalent
Albumin, blank control group are set as taking the water of equivalent, and number is A groups-embodiment 1, B groups embodiment 2, C groups-comparison respectively
Example 1, D groups-comparative example 2, E groups-comparative example 3, F groups-normal control group, G group blank control groups.Dietary structure is by professional movement
Identical recipe is outputed in nutrition.The indexs such as muscle strength are measured after 3 weeks.
Experimental result
As can be seen from the above results, it is added to the alimentation composition of conjugated linoleic acid and medium chain triglyceride, is improving body fat
Than in terms of, muscle weight and it is sleeping draw, the sleeping aspect that pushes away it is obvious, especially with do not add conjugated linoleic acid and medium chain triglyceride three
Ester, lutein, zeaxanthin are compared, and effect is more prominent, and degree of absorption is related after this may enter human body with alimentation composition.
In addition, relatively finding out with comparative example, after increasing collagen peptide and reducing the content of conjugated linoleic acid, increasing flesh effect is instead
Not as good as the effect of embodiment, this may be related with the degree of absorption of nutriment.By effective cooperation of nutrition prescription, reach fast
Speed persistently supplements energy, quickly increases flesh, prevents the loss of albumen in motion process.
Obviously, the above embodiment of the present invention be only to clearly illustrate example of the present invention, and not be pair
The restriction of embodiments of the present invention.For those of ordinary skill in the art, may be used also on the basis of the above description
To make other variations or changes in different ways.There is no necessity and possibility to exhaust all the enbodiments.It is all this
All any modification, equivalent and improvement etc., should be included in the claims in the present invention made by within the spirit and principle of invention
Protection domain within.
Claims (10)
1. at least two compositions in conjugated linoleic acid, medium chain triglyceride and PURE WHEY have in manufacture increases flesh
The purposes in alimentation composition is acted on, the alimentation composition can be functional food, health food, drug.
2. the purposes of alimentation composition according to claim 1, it is characterised in that the composition forms are tablet, glue
It is one or more in wafer, electuary, granule, pill.
3. a kind of alimentation composition with muscle-increasing function, it is characterised in that component includes:100-150 parts of PURE WHEY is total to
1-2 parts of conjugated linoleic acid, 1-4 parts of medium chain triglyceride.
4. the alimentation composition according to claim 3 with muscle-increasing function, it is characterised in that component further comprises glue
Former protein peptides 3-5 parts, 0.1-0.5 parts of vitamin C, 0.1-0.5 parts of calciferol, 0.1-0.5 parts of vitamin E, newborn mineral salt
5-20 parts, 3-10 parts of lutein, 3-10 parts of zeaxanthin.
5. the alimentation composition according to claim 4 with muscle-increasing function, it is characterised in that group is divided into PURE WHEY
120-140 parts, 1-1.5 parts of conjugated linoleic acid, 1-2 parts of medium chain triglyceride, 3-4 parts of collagen peptide, vitamin C 0.1-0.3
Part, 0.1-0.3 parts of calciferol, 0.1-0.3 parts of vitamin E, newborn 5-15 parts of mineral salt, 3-8 parts of lutein, zeaxanthin 3-
8 parts.
6. the alimentation composition according to claim 5 with muscle-increasing function, it is characterised in that collagen peptide is deep-sea
Isin glue collagen peptide, bone collagen peptide, the two proportioning are 3-5:1-2;Medium chain triglyceride is Glycerin, mixed triester with caprylic acid capric acid.
7. the alimentation composition according to claim 6 with muscle-increasing function, it is characterised in that:The composition is further wrapped
Include one kind in conventional auxiliary material, including starch, magnesium stearate, cellulose, silica, talcum powder, maltodextrin, oligosaccharide
Or it is a variety of.
8. a kind of preparation method of the alimentation composition with muscle-increasing function described in claim 5, it is characterised in that including:
Accurately weigh each raw material component;
It pelletizes after above-mentioned raw materials are sufficiently mixed.
9. preparation method according to claim 8, it is characterised in that each raw material is dry powder doses;Further pass through after granulation
UHT sterilization treatments.
10. preparation method according to claim 8, it is characterised in that raw material further comprises 1-5 parts of maltodextrin, oligomeric
It is 1-5 parts sugared.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810439855.2A CN108606327A (en) | 2018-05-09 | 2018-05-09 | It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810439855.2A CN108606327A (en) | 2018-05-09 | 2018-05-09 | It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108606327A true CN108606327A (en) | 2018-10-02 |
Family
ID=63662771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810439855.2A Pending CN108606327A (en) | 2018-05-09 | 2018-05-09 | It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108606327A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198520A (en) * | 2018-10-13 | 2019-01-15 | 赤峰禾士营养食品科技有限公司 | A kind of composite nutrient with muscle-increasing function is good for flesh powder and preparation method thereof |
CN109770367A (en) * | 2019-03-01 | 2019-05-21 | 汤臣倍健股份有限公司 | A kind of albumen powder and preparation method thereof |
CN110720641A (en) * | 2019-10-18 | 2020-01-24 | 广东海洋大学 | Protein freeze-dried block with fat-reducing and muscle-increasing effects and preparation method thereof |
CN112674208A (en) * | 2020-12-30 | 2021-04-20 | 华南农业大学 | Application of trans-10 cis-12 conjugated linoleic acid in enhancing skeletal muscle exercise endurance |
CN113573593A (en) * | 2019-03-18 | 2021-10-29 | Dds株式会社 | Ice cream rich in protein |
CN114315970A (en) * | 2022-03-15 | 2022-04-12 | 中食都庆(山东)生物技术有限公司 | Pea peptide with muscle increasing effect, and preparation method, medicament and application thereof |
CN115474688A (en) * | 2021-06-16 | 2022-12-16 | 法尔玛国际健康管理有限公司 | Nutritional composition for enhancing immunity and increasing muscle |
CN115486545A (en) * | 2022-09-16 | 2022-12-20 | 四川大学华西医院 | Low BCAAs weight-losing and muscle-increasing nutritional powder as well as preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317684A (en) * | 2007-06-08 | 2008-12-10 | 张文彪 | Solid beverage and preparation method there of |
CN103783532A (en) * | 2012-10-29 | 2014-05-14 | 杭州纽曲星生物科技有限公司 | Compound protein powder for resisting age-related sarcopenia, and preparation methods thereof |
CN107822146A (en) * | 2017-12-20 | 2018-03-23 | 大连深蓝肽科技研发有限公司 | It is a kind of that there is the PURE WHEY for increasing flesh effect |
-
2018
- 2018-05-09 CN CN201810439855.2A patent/CN108606327A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101317684A (en) * | 2007-06-08 | 2008-12-10 | 张文彪 | Solid beverage and preparation method there of |
CN103783532A (en) * | 2012-10-29 | 2014-05-14 | 杭州纽曲星生物科技有限公司 | Compound protein powder for resisting age-related sarcopenia, and preparation methods thereof |
CN107822146A (en) * | 2017-12-20 | 2018-03-23 | 大连深蓝肽科技研发有限公司 | It is a kind of that there is the PURE WHEY for increasing flesh effect |
Non-Patent Citations (1)
Title |
---|
US9MZ0: "关于蛋白粉,你想知道的都在这", 《百度贴吧,HTTPS://TIEBA.BAIDU.COM/P/5512276103?RED_ TAG=3458123260》 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198520A (en) * | 2018-10-13 | 2019-01-15 | 赤峰禾士营养食品科技有限公司 | A kind of composite nutrient with muscle-increasing function is good for flesh powder and preparation method thereof |
CN109770367A (en) * | 2019-03-01 | 2019-05-21 | 汤臣倍健股份有限公司 | A kind of albumen powder and preparation method thereof |
CN113573593A (en) * | 2019-03-18 | 2021-10-29 | Dds株式会社 | Ice cream rich in protein |
CN110720641A (en) * | 2019-10-18 | 2020-01-24 | 广东海洋大学 | Protein freeze-dried block with fat-reducing and muscle-increasing effects and preparation method thereof |
CN112674208A (en) * | 2020-12-30 | 2021-04-20 | 华南农业大学 | Application of trans-10 cis-12 conjugated linoleic acid in enhancing skeletal muscle exercise endurance |
CN115474688A (en) * | 2021-06-16 | 2022-12-16 | 法尔玛国际健康管理有限公司 | Nutritional composition for enhancing immunity and increasing muscle |
CN114315970A (en) * | 2022-03-15 | 2022-04-12 | 中食都庆(山东)生物技术有限公司 | Pea peptide with muscle increasing effect, and preparation method, medicament and application thereof |
CN115486545A (en) * | 2022-09-16 | 2022-12-20 | 四川大学华西医院 | Low BCAAs weight-losing and muscle-increasing nutritional powder as well as preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108606327A (en) | It is a kind of that there is the alimentation composition and preparation method thereof for increasing flesh effect | |
CN100502695C (en) | Nutritive powder and its making process | |
CN101209109B (en) | Composition with muscle-increasing function and beverage prepared thereby | |
CN101878849A (en) | Polypeptide powder of crocodile and preparation method and application thereof | |
CN103766696A (en) | Composition with muscle building function and preparation method thereof | |
CN103889249B (en) | Use of whey protein micelles for enhancing energy expenditure and satiety | |
CN110463989A (en) | A kind of full nutrient formulation powder of nephrosis tailored version and preparation method thereof | |
CN104939099A (en) | Additive-free compound protein powder used for human body anti-fatigue function | |
CN102415447B (en) | Calcium supplement electuary for infants and preparation process thereof | |
CN110881526A (en) | Composition for promoting iron absorption and application thereof | |
CN103283847A (en) | Multi-nutritional protein | |
CN108719984A (en) | A kind of generation meal nutrition bar and preparation method thereof for gout crowd | |
CN102631662A (en) | Composition with functions of protecting liver and relieving fatigue and preparation method of composition | |
CN107836708A (en) | A kind of composition for promoting muscle synthesis and preparation method thereof | |
CN110959796A (en) | Solid drink of sport and body-building mate and preparation method thereof | |
KR20140106274A (en) | Health foods composition for diet and muscle strengthen and manufacturing of the same | |
ES2688181T3 (en) | Composition to improve nutritional status, reduce the frequency of fever and / or increase the immune capacity of elderly people | |
CN106418067A (en) | Health beverage capable of replenishing physical power and relieving fatigue | |
CN108308621A (en) | A kind of weight losing meal-replacing powder rich in rice oligopeptide | |
CN105533699A (en) | Compound for supplementing zinc and vitamin in children as well as preparation method and application thereof | |
CN103690564A (en) | Application of wood frog high protein calcium powder in preparation of anti-fatigue health-care products or drugs | |
CN107712065A (en) | A kind of person in middle and old age are formulated peptide milk powder and preparation method thereof | |
CN102613559A (en) | Composite protein powder capsule and preparation method thereof | |
RU2491948C1 (en) | Composition for prevention of iron deficiency anemia | |
Naclerio et al. | Effectiveness of whey protein supplement in resistance trained individuals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181002 |
|
WD01 | Invention patent application deemed withdrawn after publication |